" class="no-js "lang="en-US"> Eric Smith - Medtech Alert
Saturday, August 23, 2025
Eric Smith

Eric Smith

About Eric Smith

Eric Smith, MD PhD moved to Boston after spending 8 years at Memorial Sloan Kettering Cancer Center, most recently serving as faculty in the Center for Cell Engineering, Cellular Therapeutics Center, and the Myeloma Service before joining DFCI. Dr. Smith’s pre-clinical work has resulted in nine awarded or pending patents; multiple products stemming from his lab work have been translated to the clinic. He is looking forward to expanding his lab group at Dana-Farber Cancer Institute and is actively recruiting.

Related Story

Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment

June 16 2021

Harbour BioMed (HKEX: 02142) announced today it has entered into a multi-year, multifaceted research collaboration […]